HDAC9 and medullary thyroid gland carcinoma: As a comparison to other NET cell lines, the effect of HDAC inhibitor treatment on SSTR2 protein incidence was also determined in medullary thyroid cancer cell lines: TT and MZ (Figure 3A, Figure S3C,D).